These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2993686)

  • 21. Counterimmunoelectrophoresis for detection of human serum antibody to HTLV-III.
    Blaser MJ; Cohn DL; Cody HJ; Penley KA; Judson FN; Saxinger WC; Weiss SH
    J Immunol Methods; 1986 Jul; 91(2):181-6. PubMed ID: 3016097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives or evidence of viral exposure?
    Moore JD; Cone EJ; Alexander SS
    N Engl J Med; 1986 May; 314(21):1387-8. PubMed ID: 3010112
    [No Abstract]   [Full Text] [Related]  

  • 23. Photometric reading of anti-HTLV-III ELISA kits.
    Grunnet N; Jersild C; Georgsen J
    Lancet; 1985 Dec; 2(8467):1302. PubMed ID: 2866361
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
    Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
    JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HTLV-III/LAV infection in hemodialysis patients.
    Peterman TA; Lang GR; Mikos NJ; Solomon SL; Schable CA; Feorino PM; Britz JA; Allen JR
    JAMA; 1986 May; 255(17):2324-6. PubMed ID: 3007792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AIDS: recent events.
    Hellstrom JG; Chambers DC; Bradley WR
    Med Sect Proc; 1985; ():69-77. PubMed ID: 3014497
    [No Abstract]   [Full Text] [Related]  

  • 27. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jun; 35(23):376-8, 383. PubMed ID: 3012309
    [No Abstract]   [Full Text] [Related]  

  • 28. Relation of HTLV-III seropositivity and lymphadenopathy.
    Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
    Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificity.
    Petricciani JC
    Ann Intern Med; 1985 Nov; 103(5):726-9. PubMed ID: 2996408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How should we handle the ethical questions regarding information to donors and patients and the practical implications regarding deferral of donors and handling of donated blood in the event of introducing a screening test for HTLV-III as in order to prevent transmission of AIDS by blood transfusion?
    Bove JR; Dodd RY; Miller WV; Sandler SG
    Vox Sang; 1985; 49(3):234-9. PubMed ID: 2996229
    [No Abstract]   [Full Text] [Related]  

  • 31. Heat inactivation of serum may interfere with tests for antibodies to LAV/HTLV-III.
    van Beers D; Duys M; Maes M; Biarent D; Haumont D
    J Virol Methods; 1985 Dec; 12(3-4):329. PubMed ID: 3009518
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
    Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL
    Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
    Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
    Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-HTLV-III antibody incidence.
    Goldbaum J
    Med J Aust; 1985 Sep; 143(6):261-2. PubMed ID: 2993832
    [No Abstract]   [Full Text] [Related]  

  • 35. False-positive anti-HTLV-III assay results and HLA-DR4.
    Kenrick KG; Bolton W; Doran TJ
    Med J Aust; 1985 Jul; 143(2):88-9. PubMed ID: 2991712
    [No Abstract]   [Full Text] [Related]  

  • 36. Infectious complications of blood transfusions.
    Berkman SA
    Semin Oncol; 1984 Mar; 11(1):68-76. PubMed ID: 6326332
    [No Abstract]   [Full Text] [Related]  

  • 37. Importance of confirmatory tests after strongly positive HTLV-III screening tests.
    Martin PW; Burger DR; Caouette S; Goldstein AS; Peetoom F
    N Engl J Med; 1986 Jun; 314(24):1577. PubMed ID: 3012336
    [No Abstract]   [Full Text] [Related]  

  • 38. Leads from the MMWR. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus.
    JAMA; 1986 Aug; 256(6):703-4. PubMed ID: 3014176
    [No Abstract]   [Full Text] [Related]  

  • 39. [Detection of HTLV-III antibodies using ELISA and the western blot].
    Kunz C; Heinz FX
    Wien Klin Wochenschr; 1985 Nov; 97(22):829-32. PubMed ID: 3002046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-III/LAV-antibody-positive soldiers in Berlin.
    James JJ; Morgenstern MA; Hatten JA
    N Engl J Med; 1986 Jan; 314(1):55-6. PubMed ID: 2999600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.